Cargando…

Dhikr Therapy for Reducing Anxiety in Cancer Patients

OBJECTIVE: Anxiety in cancer patients can affect recovery time, medication adherence, and patient quality of life. Some studies show that dhikr therapy can improve relaxation and can reduce anxiety, but research on dhikr therapy in cancer patients is still not widely done. This study aims to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sulistyawati, Ririn Afrian, Probosuseno, Setiyarini, Sri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696810/
https://www.ncbi.nlm.nih.gov/pubmed/31572762
http://dx.doi.org/10.4103/apjon.apjon_33_19
_version_ 1783444332008701952
author Sulistyawati, Ririn Afrian
Probosuseno,
Setiyarini, Sri
author_facet Sulistyawati, Ririn Afrian
Probosuseno,
Setiyarini, Sri
author_sort Sulistyawati, Ririn Afrian
collection PubMed
description OBJECTIVE: Anxiety in cancer patients can affect recovery time, medication adherence, and patient quality of life. Some studies show that dhikr therapy can improve relaxation and can reduce anxiety, but research on dhikr therapy in cancer patients is still not widely done. This study aims to determine the effect of dhikr therapy on reducing anxiety in cancer patients. METHODS: This study used a quantitative method with a quasi-experimental-nonequivalent control group design. The study was conducted in April–May 2018, with respondents 20 people in the intervention group and 20 people in the control group. Dhikr therapy is given once a day in the intervention group with a minimum time of 10 min. Anxiety was measured using the Visual Analog Scale for Anxiety. The effect of dhikr therapy was measured using the Mann–Whitney and effect size (ES). RESULTS: There were a statistically significant differences in the anxiety level of patients in the intervention group and the control group, with a value of P = 0.001 (P < 0.05) and ES = 0.87 (ES > 0.5) indicating the influence of dhikr therapy in reducing patient anxiety. CONCLUSIONS: Dhikr therapy has a great effect on reducing anxiety in cancer patients.
format Online
Article
Text
id pubmed-6696810
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66968102019-10-01 Dhikr Therapy for Reducing Anxiety in Cancer Patients Sulistyawati, Ririn Afrian Probosuseno, Setiyarini, Sri Asia Pac J Oncol Nurs Original Article OBJECTIVE: Anxiety in cancer patients can affect recovery time, medication adherence, and patient quality of life. Some studies show that dhikr therapy can improve relaxation and can reduce anxiety, but research on dhikr therapy in cancer patients is still not widely done. This study aims to determine the effect of dhikr therapy on reducing anxiety in cancer patients. METHODS: This study used a quantitative method with a quasi-experimental-nonequivalent control group design. The study was conducted in April–May 2018, with respondents 20 people in the intervention group and 20 people in the control group. Dhikr therapy is given once a day in the intervention group with a minimum time of 10 min. Anxiety was measured using the Visual Analog Scale for Anxiety. The effect of dhikr therapy was measured using the Mann–Whitney and effect size (ES). RESULTS: There were a statistically significant differences in the anxiety level of patients in the intervention group and the control group, with a value of P = 0.001 (P < 0.05) and ES = 0.87 (ES > 0.5) indicating the influence of dhikr therapy in reducing patient anxiety. CONCLUSIONS: Dhikr therapy has a great effect on reducing anxiety in cancer patients. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6696810/ /pubmed/31572762 http://dx.doi.org/10.4103/apjon.apjon_33_19 Text en Copyright: © 2019 Ann & Joshua Medical Publishing Co. Ltd http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sulistyawati, Ririn Afrian
Probosuseno,
Setiyarini, Sri
Dhikr Therapy for Reducing Anxiety in Cancer Patients
title Dhikr Therapy for Reducing Anxiety in Cancer Patients
title_full Dhikr Therapy for Reducing Anxiety in Cancer Patients
title_fullStr Dhikr Therapy for Reducing Anxiety in Cancer Patients
title_full_unstemmed Dhikr Therapy for Reducing Anxiety in Cancer Patients
title_short Dhikr Therapy for Reducing Anxiety in Cancer Patients
title_sort dhikr therapy for reducing anxiety in cancer patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696810/
https://www.ncbi.nlm.nih.gov/pubmed/31572762
http://dx.doi.org/10.4103/apjon.apjon_33_19
work_keys_str_mv AT sulistyawatiririnafrian dhikrtherapyforreducinganxietyincancerpatients
AT probosuseno dhikrtherapyforreducinganxietyincancerpatients
AT setiyarinisri dhikrtherapyforreducinganxietyincancerpatients